1 Study Coverage
1.1 Cognition-Enhancing Drugs Product Introduction
1.2 Global Cognition-Enhancing Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cognition-Enhancing Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Cognition-Enhancing Drugs Sales in Volume for the Year 2017-2028
1.3 United States Cognition-Enhancing Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Cognition-Enhancing Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Cognition-Enhancing Drugs Sales in Volume for the Year 2017-2028
1.4 Cognition-Enhancing Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Cognition-Enhancing Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Cognition-Enhancing Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Cognition-Enhancing Drugs Market Dynamics
1.5.1 Cognition-Enhancing Drugs Industry Trends
1.5.2 Cognition-Enhancing Drugs Market Drivers
1.5.3 Cognition-Enhancing Drugs Market Challenges
1.5.4 Cognition-Enhancing Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Cognition-Enhancing Drugs Market Segment by Type
2.1.1 Oral
2.1.2 Injection
2.2 Global Cognition-Enhancing Drugs Market Size by Type
2.2.1 Global Cognition-Enhancing Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Cognition-Enhancing Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Cognition-Enhancing Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Cognition-Enhancing Drugs Market Size by Type
2.3.1 United States Cognition-Enhancing Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Cognition-Enhancing Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Cognition-Enhancing Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Cognition-Enhancing Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Drug Stores
3.1.3 Retail Pharmacies
3.2 Global Cognition-Enhancing Drugs Market Size by Application
3.2.1 Global Cognition-Enhancing Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Cognition-Enhancing Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Cognition-Enhancing Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Cognition-Enhancing Drugs Market Size by Application
3.3.1 United States Cognition-Enhancing Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Cognition-Enhancing Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Cognition-Enhancing Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Cognition-Enhancing Drugs Competitor Landscape by Company
4.1 Global Cognition-Enhancing Drugs Market Size by Company
4.1.1 Top Global Cognition-Enhancing Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Cognition-Enhancing Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Cognition-Enhancing Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Cognition-Enhancing Drugs Price by Manufacturer (2017-2022)
4.2 Global Cognition-Enhancing Drugs Concentration Ratio (CR)
4.2.1 Cognition-Enhancing Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cognition-Enhancing Drugs in 2021
4.2.3 Global Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cognition-Enhancing Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Cognition-Enhancing Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Cognition-Enhancing Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Cognition-Enhancing Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Cognition-Enhancing Drugs Market Size by Company
4.5.1 Top Cognition-Enhancing Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cognition-Enhancing Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Cognition-Enhancing Drugs Sales by Players (2020, 2021 & 2022)
5 Global Cognition-Enhancing Drugs Market Size by Region
5.1 Global Cognition-Enhancing Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cognition-Enhancing Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Cognition-Enhancing Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Cognition-Enhancing Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Cognition-Enhancing Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Cognition-Enhancing Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Cognition-Enhancing Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Cognition-Enhancing Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cognition-Enhancing Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Cognition-Enhancing Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Cognition-Enhancing Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cognition-Enhancing Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Accelerated Intelligence
7.1.1 Accelerated Intelligence Corporation Information
7.1.2 Accelerated Intelligence Description and Business Overview
7.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Products Offered
7.1.5 Accelerated Intelligence Recent Development
7.2 Cognition Therapeutics
7.2.1 Cognition Therapeutics Corporation Information
7.2.2 Cognition Therapeutics Description and Business Overview
7.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Products Offered
7.2.5 Cognition Therapeutics Recent Development
7.3 Cogstate
7.3.1 Cogstate Corporation Information
7.3.2 Cogstate Description and Business Overview
7.3.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Cogstate Cognition-Enhancing Drugs Products Offered
7.3.5 Cogstate Recent Development
7.4 HVMN
7.4.1 HVMN Corporation Information
7.4.2 HVMN Description and Business Overview
7.4.3 HVMN Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 HVMN Cognition-Enhancing Drugs Products Offered
7.4.5 HVMN Recent Development
7.5 Biogen Idec
7.5.1 Biogen Idec Corporation Information
7.5.2 Biogen Idec Description and Business Overview
7.5.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Biogen Idec Cognition-Enhancing Drugs Products Offered
7.5.5 Biogen Idec Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Cognition-Enhancing Drugs Industry Chain Analysis
8.2 Cognition-Enhancing Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Cognition-Enhancing Drugs Distributors
8.3 Cognition-Enhancing Drugs Production Mode & Process
8.4 Cognition-Enhancing Drugs Sales and Marketing
8.4.1 Cognition-Enhancing Drugs Sales Channels
8.4.2 Cognition-Enhancing Drugs Distributors
8.5 Cognition-Enhancing Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Cognition-Enhancing Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Cognition-Enhancing Drugs Market Trends
Table 3. Cognition-Enhancing Drugs Market Drivers
Table 4. Cognition-Enhancing Drugs Market Challenges
Table 5. Cognition-Enhancing Drugs Market Restraints
Table 6. Global Cognition-Enhancing Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Cognition-Enhancing Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Cognition-Enhancing Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Cognition-Enhancing Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Cognition-Enhancing Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Cognition-Enhancing Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Cognition-Enhancing Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Cognition-Enhancing Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Cognition-Enhancing Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Cognition-Enhancing Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Cognition-Enhancing Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognition-Enhancing Drugs as of 2021)
Table 18. Top Players of Cognition-Enhancing Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Cognition-Enhancing Drugs Product Type
Table 20. Date of International Manufacturers Enter into Cognition-Enhancing Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Cognition-Enhancing Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Cognition-Enhancing Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Cognition-Enhancing Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Cognition-Enhancing Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Cognition-Enhancing Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Cognition-Enhancing Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Cognition-Enhancing Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Cognition-Enhancing Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Cognition-Enhancing Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Cognition-Enhancing Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Cognition-Enhancing Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Accelerated Intelligence Corporation Information
Table 43. Accelerated Intelligence Description and Business Overview
Table 44. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Accelerated Intelligence Cognition-Enhancing Drugs Product
Table 46. Accelerated Intelligence Recent Development
Table 47. Cognition Therapeutics Corporation Information
Table 48. Cognition Therapeutics Description and Business Overview
Table 49. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Cognition Therapeutics Product
Table 51. Cognition Therapeutics Recent Development
Table 52. Cogstate Corporation Information
Table 53. Cogstate Description and Business Overview
Table 54. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Cogstate Product
Table 56. Cogstate Recent Development
Table 57. HVMN Corporation Information
Table 58. HVMN Description and Business Overview
Table 59. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. HVMN Product
Table 61. HVMN Recent Development
Table 62. Biogen Idec Corporation Information
Table 63. Biogen Idec Description and Business Overview
Table 64. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Biogen Idec Product
Table 66. Biogen Idec Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Cognition-Enhancing Drugs Customers List
Table 70. Cognition-Enhancing Drugs Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Cognition-Enhancing Drugs Product Picture
Figure 2. Global Cognition-Enhancing Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Cognition-Enhancing Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Cognition-Enhancing Drugs Sales 2017-2028 (K MT)
Figure 5. United States Cognition-Enhancing Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Cognition-Enhancing Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Cognition-Enhancing Drugs Sales 2017-2028 (K MT)
Figure 8. United States Cognition-Enhancing Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Cognition-Enhancing Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Cognition-Enhancing Drugs Report Years Considered
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injection
Figure 13. Global Cognition-Enhancing Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Cognition-Enhancing Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Cognition-Enhancing Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Cognition-Enhancing Drugs Sales by Type (2017-2028) & (K MT)
Figure 17. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Cognition-Enhancing Drugs Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Cognition-Enhancing Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Cognition-Enhancing Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Cognition-Enhancing Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Cognition-Enhancing Drugs Sales by Type (2017-2028) & (K MT)
Figure 23. United States Cognition-Enhancing Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Cognition-Enhancing Drugs Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of Hospital Pharmacies
Figure 26. Product Picture of Drug Stores
Figure 27. Product Picture of Retail Pharmacies
Figure 28. Global Cognition-Enhancing Drugs Market Share by Application in 2022 & 2028
Figure 29. Global Cognition-Enhancing Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Cognition-Enhancing Drugs Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Cognition-Enhancing Drugs Sales by Application (2017-2028) & (K MT)
Figure 32. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Cognition-Enhancing Drugs Price by Application (2017-2028) & (USD/MT)
Figure 34. United States Cognition-Enhancing Drugs Market Share by Application in 2022 & 2028
Figure 35. United States Cognition-Enhancing Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Cognition-Enhancing Drugs Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Cognition-Enhancing Drugs Sales by Application (2017-2028) & (K MT)
Figure 38. United States Cognition-Enhancing Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Cognition-Enhancing Drugs Price by Application (2017-2028) & (USD/MT)
Figure 40. North America Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 41. North America Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 45. Europe Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 52. Asia-Pacific Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 64. Latin America Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 69. Middle East & Africa Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Cognition-Enhancing Drugs Value Chain
Figure 74. Cognition-Enhancing Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Accelerated Intelligence Cognition Therapeutics Cogstate HVMN Biogen Idec